NEW YORK (GenomeWeb News) – Olink Bioscience today said that Abnova will distribute the firm's Duolink in situ PLATM product line in the US.
The agreement expands a previous pact between the firms, under which they agreed to co-develop and co-market hundreds of target-specific assays for studies of protein phosphorylation and protein interactions based on antibodies from Abnova and the Duolink product line.
Peter Karlberg, director of sales and marketing for Olink, said that Abnova is "a perfect partner for Olink Bioscience to accelerate our penetration of the US market and to establish Duolink as a standard for high-performance in situ studies of proteins, protein interactions and protein modifications."
Financial and other terms of the agreement were not disclosed.